Literature DB >> 7717288

Short-term use of intravenous milrinone for heart failure.

M A Konstam, R J Cody.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7717288     DOI： 10.1016/s0002-9149(99)80420-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

1.  Effect of phosphodiesterase III inhibitor on contractility, afterload, and vascular capacitance during right heart bypass preparation.

Authors:  Y Tanoue; S Morita; I Nagano; Y Ochiai; R Tominaga; Y Kawachi; H Yasui
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-10

2.  Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.

Authors:  Oleg E Osadchii; Angela J Woodiwiss; Gavin R Norton
Journal:  Pflugers Arch       Date:  2005-12-17       Impact factor: 3.657

3.  Clinical experience of milrinone as a pharmacological bridge to heart transplantation.

Authors:  T Koyanagi; S Kyo; H Ouchi; H Asano; Y Yokote; R Omoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-07

Review 4.  Drugs to facilitate recovery of neuromuscular blockade and muscle strength.

Authors:  Yuhji Saitoh
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

5.  Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.

Authors:  J H O'Keefe; A Magalski; T L Stevens; D R Bresnahan; K Alaswad; S K Krueger; T M Bateman
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

6.  Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.

Authors:  Delphine Mika; Pierre Bobin; Martine Pomérance; Patrick Lechêne; Ruth E Westenbroek; William A Catterall; Grégoire Vandecasteele; Jérôme Leroy; Rodolphe Fischmeister
Journal:  Cardiovasc Res       Date:  2013-08-09       Impact factor: 10.787

7.  Repetitive milrinone therapy in ambulatory advanced heart failure patients.

Authors:  Michal Laufer-Perl; Sapir Sadon; David Zahler; Assi Milwidsky; Ben Sadeh; Orly Sapir; Yoav Granot; Liuba Korotetski; Liora Ketchker; Maayan Rosh; Shmuel Banai; Ofer Havakuk
Journal:  Clin Cardiol       Date:  2022-03-04       Impact factor: 3.287

8.  Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.

Authors:  Mai Mohsen Abdelazziz; Hadil Magdi Abdelhamid
Journal:  Ann Card Anaesth       Date:  2019 Apr-Jun

9.  Effect of milrinone on cardiac functions in patients undergoing coronary artery bypass graft: a meta-analysis of randomized clinical trials.

Authors:  Zhigang You; Lin Huang; Xiaoshu Cheng; Qinghua Wu; Xinghua Jiang; Yanqing Wu
Journal:  Drug Des Devel Ther       Date:  2015-12-24       Impact factor: 4.162
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.